PMID: 2493638Jan 1, 1989Paper

Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review

Pharmacotherapy
J Sahai, A J Berry

Abstract

Pneumocystis carinii pneumonia (PCP) is the most common opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS). Eflornithine is an antiprotozoal agent active against P. carinii. It acts by inhibiting ornithine decarboxylase, an enzyme that is essential for cellular function. The drug is initially administered intravenously, followed by oral therapy. Eflornithine has been used on a compassionate basis in AIDS patients with PCP who were intolerant of or unresponsive to traditional agents. Overall, the response rate has been about 35%; however, conclusions are difficult to make since patients had different stages of disease and received treatment for varying periods of time. Side effects include depression of bone marrow function, diarrhea, hearing loss, seizures, alterations in liver function tests, and rash. While the need for safer and more efficacious antipneumocystis drugs grows, widespread use of seemingly promising agents should be based on well-conducted clinical trials.

References

Jan 1, 1979·Biochemical Pharmacology·D V Maudsley
Jul 20, 1978·Nature·S S Cohen
Jul 1, 1975·Nucleic Acids Research·T T SakaiS S Cohen
Oct 15, 1987·The New England Journal of Medicine·W T Hughes
May 1, 1986·Nature·J CoffinP Vogt
Jul 1, 1986·Annals of Internal Medicine·R A BarbarashS A Sahn
Oct 1, 1987·Infection and Immunity·F KierszenbaumA Sjoerdsma
Sep 1, 1987·The Journal of Antimicrobial Chemotherapy·A F BremnerM J North
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·A B ClarksonC Rosenberg
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·M T CushionP D Walzer
Jun 1, 1982·Annals of Internal Medicine·D MildvanI Spigland
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·W T Hughes, B L Smith
Mar 1, 1984·Clinical Pharmacology and Therapeutics·A Sjoerdsma, P J Schechter
Oct 1, 1984·Annals of Internal Medicine·D P KotlerP R Holt
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·H Tabor, C W Tabor
Nov 1, 1982·The American Journal of Physiology·A E Pegg, P P McCann
Jan 1, 1982·Transactions of the Royal Society of Tropical Medicine and Hygiene·J M GilletF Herman
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E HubermanT Slaga

❮ Previous
Next ❯

Citations

Jun 1, 1995·Journal of Clinical Pharmacy and Therapeutics·A E Jolley, J G Hastings
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Chung-Ping LiaoChao-Hung Lee
Jul 1, 1997·Journal of Communication Disorders·G S Scott, T L Layton
Jan 1, 1992·Pharmacology & Therapeutics·P P McCann, A E Pegg
Jan 1, 1991·International Journal of Antimicrobial Agents·I Varthalitis, F Meunier
Oct 1, 1993·Cancer Treatment Reviews·I Varthalitis, F Meunier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.